Loading fund overlap…
22 of 127 unique stocks in common · Jaccard: 17.3%
A weighted portfolio overlap of 29.18% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹29.18 is allocated to the exact same companies at the same relative proportions. The schemes share 22 common holdings.
The largest overlapping asset in their portfolios is Sun Pharmaceutical Industries, which commands a weight of 13.91% in Back to Index and 8.35% in DSP Healthcare Fund. Holding both schemes increases your concentration in Sun Pharmaceutical Industries rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Back | in DSP |
|---|---|---|
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 13.91% | 8.35% |
| CiplaPharmaceuticals & Biotechnology | 5.28% | 7.68% |
| Apollo Hospitals EnterpriseHealthcare Services | 5.55% | 4.81% |
| Laurus LabsPharmaceuticals & Biotechnology | 3.04% | 3.76% |
| IPCA LaboratoriesPharmaceuticals & Biotechnology | 1.52% | 7.81% |
| Sai Life SciencesPharmaceuticals & Biotechnology | 1.03% | 6.86% |
| Gland PharmaPharmaceuticals & Biotechnology | 0.99% | 6.26% |
| Alkem LaboratoriesPharmaceuticals & Biotechnology | 2.25% | 0.62% |
| Cohance LifesciencesPharmaceuticals & Biotechnology | 0.55% | 4.15% |
| PfizerPharmaceuticals & Biotechnology | 0.51% | 2.79% |
| Emcure PharmaceuticalsPharmaceuticals & Biotechnology | 0.41% | 1.51% |
| Vijaya Diagnostic CentreHealthcare Services | 0.39% | 3.70% |
| Jupiter Life Line HospitalsHealthcare Services | 0.33% | 0.38% |
| Alembic PharmaceuticalsPharmaceuticals & Biotechnology | 0.30% | 3.21% |
| Procter & Gamble HealthPharmaceuticals & Biotechnology | 0.29% | 2.92% |
| Concord BiotechPharmaceuticals & Biotechnology | 0.27% | 1.58% |
| Kovai Medical Center and HospitalHealthcare Services | 0.19% | 2.68% |
| Aarti DrugsPharmaceuticals & Biotechnology | 0.09% | 0.98% |
| Indoco RemediesPharmaceuticals & Biotechnology | 0.06% | 2.06% |
| Nephrocare Health ServicesHealthcare Services | 0.06% | 1.15% |
| Unichem LaboratoriesPharmaceuticals & Biotechnology | 0.06% | 0.90% |
| Laxmi DentalHealthcare Equipment & Supplies | 0.03% | 0.20% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.